Literature DB >> 26422160

MOLECULAR CHARACTERIZATION OF AMERICAN CUTANEOUS LEISHMANIASIS IN THE TRI‑BORDER AREA OF ASSIS BRASIL, ACRE STATE, BRAZIL.

Carolina Bioni Garcia Teles1, Jansen Fernandes Medeiros1, Ana Paula de Azevedo dos Santos1, Luís Antônio Rodrigues de Freitas2, Tony Hiroshi Katsuragawa1, Lilian Motta Cantanhêde1, Ricardo de Godoi Mattos Ferreira1, Luís Marcelo Aranha Camarg3.   

Abstract

In this study, Leishmania species were identified by Polymerase Chain Reaction (PCR). The epidemiology of patients suspected of having American Cutaneous Leishmaniasis in the municipality of Assis Brasil, Acre State, located in the Brazil/Peru/Bolivia tri-border was also investigated. By PCR, the DNA of Leishmania was detected in 100% of the cases (37 samples) and a PCR-Restriction Fragment Length Polymorphism (RFLP) of the hsp 70 gene identified the species in 32 samples: Leishmania (Viannia) braziliensis (65.6%) , L. (V.) shawi (28.1%) , L. (V.) guyanensis (3.1%) and mixed infection L. (V.) guyanensis and L. (Leishmania) amazonensis(3.1%)This is the first report of L. (V.) shawi and L. (L.) amazonensis in Acre. The two predominant species were found in patients living in urban and rural areas. Most cases were found in males living in rural areas for at least three years and involved in rural work. This suggests, in most cases, a possible transmission of the disease from a rural/forest source, although some patients had not engaged in activities associated with permanence in forestall areas, which indicate a possible sandflies adaptation to the periurban setting.

Entities:  

Mesh:

Year:  2015        PMID: 26422160      PMCID: PMC4616921          DOI: 10.1590/S0036-46652015000400012

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


INTRODUCTION

American Cutaneous Leishmaniasis (ACL) is an infectious-parasitic disease caused by different species of protozoa of the Leishmaniagenus that is transmitted to humans by phlebotomine flies.19 Although there was a decreased incidence of ACL in Brazil, due to Brazilian socioeconomic improvement and increased environmental monitoring over the last 15 years, providing a decrease of people exposed to the vectors26, the disease still persists in the country with a high number of cases. Between 2010 and 2012, 68,855 occurrences of ACL were recorded in Brazil. The disease occurs in several endemic areas, 40% of which are found in the North, the area of higher endemicity. Acre was the unit of the federation with the highest incidence of ACL, with 141.64 cases per 100,000 inhabitants in 20104. In spite of the high incidence of ACL in Acre, the published clinical and demographic studies about this disease are based on the data provided by the Ministry of Health16 , 22 , 23. The only exception is an epidemiological study in Rio Branco, in which Leishmaniaspecies were characterized using molecular biology techniques27. The identification of Leishmania species from endemic areas is an important step in our understanding of the epidemiology of ACL that could improve its diagnostic and prognostic, and also contribute to the implementation of control and epidemiological surveillance measures20 , 27. The Polymerase Chain Reaction - Restriction Fragment Length Polymorphism (PCR-RFLP) of samples obtained from leishmaniasis-like lesions - can distinguish the different pathogenic species and this method is more sensitive than the conventional method, which is a parasitological examination performed with an optical microscope7 , 20. In the majority of Acre municipalities, the reports of ACL are based on non-specific tests, such as the Montenegro's intradermal-reaction, direct microscopic examination and clinical-epidemiological findings16 , 22 , 23. In Acre, the epidemiological profile study of ACL and its control must be considered in a special context, because this is a region that borders with two endemic countries for ACL: Peru/Madre de Dios, with 380 cases/100,000 inhabitants from 2000 to 2012 and Bolivia/Pando, with 659 cases/100,000 inhabitants in 20123 , 18. Assis Brasil/Brazil is located in the microregion of Brasileia, which, together with the microregion of Rio Branco, is an endemic area of epidemiological relevance for ACL in the Acre State 22 , 23. Between 2007 and 2010, a total of 227 cases were reported in the municipality, which corresponds to a mean detection coefficient of 1,027 ACL cases per 100,000 inhabitants.4 This was the first study performed in the municipality that used molecular methods to characterize the Leishmania from ACL patients The diagnostic of ACL was performed on 37 patients that spontaneously attended the Basic Urban Health Unit of Assis Brasil between August 2012 and December 2013 with cutaneous lesions raising the suspicion of ACL. The study was approved by the Ethics Committee in Human Research of the Instituto de Ciências Biomédicas - USP (nº 77885/2012). Each patient underwent a clinical examination. A biopsy was collected and sent to the Genetics Laboratory of Fiocruz Rondônia for the PCR assay. During the medical appointment, the following clinicalepidemiological data were collected: sex, age, address (rural or urban), type of lesion (cutaneous, cutaneous-mucosal, and diffuse cutaneous), time since the lesion was detected, if it was a recurring lesion, what type of treatment had been used (which drug) and whether there had been any progress towards the clinical cure of the lesion. Additional information on the patients' occupations was also gathered in the following categories: rural (such as farmers, herdsmen, professors and students from rural areas), non-rural (military personnel, journalists and drivers) and others (housewives, retired workers and children). The DNA was extracted from the biopsies according to the recommendations of the manufacturer (PureLink Genomic DNA Mini Kit(tm); Invitrogen(r) Carlsbad, CA, USA). To identify the Leishmania genus, PCR was performed as described by OLIVEIRA et al.16. This PCR targeting a conserved region of the Leishmania kDNA minicircle (PCR mkDNA) was performed with primers 5'-GGG(GT) AGGGGCGTTCT(G/C)CGAA-3' and 5'-(G/C)(G/C)(G/C)(A/T) CTAT(A/T)TTACAC CAACCCC3'. The final volume of the PCR reactions was 25 µL (18.7 µL of Milli-Q water; 2.5 µL of Buffer Green; 0.75 µL of MgCl2 (2 mM final); 0.38 µL of each mkDNA primer (1 µmol final); 0.50 µL of dNTPs (0.2 mM final); 0.25 µL of Taq Polymerase (1.25 U); 2 µL of DNA). The amplification conditions were: 94 ºC denaturation for five minutes, 40 cycles at 94 ºC for 30 seconds, 55 ºC for 30 seconds and 72 ºC for 45 seconds, and a final extension at 72 ºC for 10 minutes. In order to identify the Leishmania species from the human biopsies, a fragment of the hsp70 gene was amplified (PCR hsp70) with primers hsp 70cF 5'-GGACGAGATCGAGCGCATG GT-3' and hsp 70cR 5'-TCCTTCGACGCCTCCTGGTTG-3' (adapted from GRAÇA et al.)8. The PCR mix composition was: 36.25 µL of Milli-Q water, 5.0 µL of Buffer Green; 1.5 µL of MgCl2 (2 mM); 1.0 µL of each primer hsp70 (1 µmol final); 2.0 µL of dNTPs (0.2 mM final); 0.5 µL of Taq Polymerase (1.25 U); 5.0 µL of DNA, for a final volume of 52.25 µL. The amplification conditions were: 94 ºC denaturation for four minutes, 33 cycles at 94 ºC for 15 seconds, 58 ºC for 30 seconds and 72 ºC for 30 seconds, and a final extension at 72 ºC for 10 minutes. The mkDNA (120 pb) hsp70 (234 pb) amplicons were analyzed on a 2% agarose gel stained with GelRed and examined under UV light. For the digestion of the hsp70 amplicons, the restriction enzymes HaeIII (Invitrogen(r), USA) and BstUI (Bio Labs(r), New England) were used in independent reactions according to the recommendations of the manufacturer. The resulting products of the restriction digestion were analyzed on a silver-stained 12% polyacrylamide gel (Fig. 1). As a positive control for the PCR and RFLP reactions, DNAs of reference strains of the Leishmania collection from the Instituto Oswaldo Cruz (CLIOC) were used, namely: L. (V.) braziliensis (IOCL 566), L.(V.) guyanensis (IOCL 565), L. (V.) lainsoni(IOCL 1023), L. (V.) naiffi (IOCL 1365), L. (V.) shawi (IOCL 1545) and L. (L.) amazonensis (IOCL 575). As negative controls, a PCR reaction mix without DNA was used.
Fig.1

Amplicons of hsp70 (234 pb) after digestion with Hae III and BstUI from samples of patients suspected of having ACL. Silver-stained 12% polyacrylamide gel. Lanes 1 and 10: negative control; Lanes 2 and 11: sample from patient 01; Lanes 3 and 12: sample from patient 02; Lanes 4 and 13: sample from patient 03; Lanes 5 and 14: sample from patient 04 with mixed infection; Ls: L. (V.) shawi; Lb: L. (V.) braziliensis; Lg: L. (V.) guyanensis; La: L. (L.) amazonensis. M: 100 pb molecular weight marker (Invitrogen(r)).

Measures of central tendency (mean, Md = median, standard deviation, and Q = quartiles) were used for the descriptive analysis, and to calculate the proportions and the confidence interval (IC 95%) for each variable. PCR for the genus Leishmania was positive in the 37 samples. The hsp70 PCR identified four species in 32 (86.4%) samples: Leishmania (V.) braziliensis (21/32; 65.6%), L. (V.) guyanensis (1/32; 3.1%), L. (V.) shawi (9/32; 28.1%) and a mixed infection (1/32; 3.1%) by L. (V.) guyanensis and L. (L.) amazonensis; notably, this is the first report of L. (V.) shawi and L. (L.) amazonensis in Acre. In the microregion of Rio Branco, besides Leishmania (V.) braziliensis and L. (V.) guyanensis, L. (V.) lainsoni and L. (V.) naiffi have also been identified27. Except for L. (V.) shawi, the species that have been described in Acre were also found in other regions of Occidental Amazonia: in Rondônia State, species Leishmania (V.) braziliensis, L. (V.) lainsoni, and L. (V.) guyanensis 21 were reported; and in Amazonas State, L. (L.) amazonensis, L. (V.) braziliensis, L. (V.) guyanensis and L. (V.) naiffi have been detected1 , 9 , 25, L. (V.) guyanensis being the most frequent species6 , 10. L. (V.) braziliensis was the most common species in this study, similar to observations in the microregion of Rio Branco and other areas in Bolivia and in the Peruvian State of Madre de Dios 8 , 27 , 28. It is possible that the high number of L. (V.) braziliensis in Assis Brasil/Brazil and its broad geographical spreading in the municipality (Fig. 2) was related to the several phlebotominae species adapted to both the rural/forest and peridomicile environments. Lu. wellcomei, Lu. migonei, Lu. carrerai, Lu. davisi and Lu. whitmani were the potential L. braziliensisvectors19, the latter two notable for their relative abundance in Acre State 2 , 24.
Fig. 2

Geographic distribution of the Leishmania spp. from patients attended in Assis Brasil (AC) suspected of having ACL. Each symbol represents one or more specimens collected in a given region. 1: Mamoadate Indigenous reserve; 2: Icuriã Extractive rubber reserve; 3: Guanabara Extractive rubber reserve; 4: São Francisco Extractive rubber reserve; 5: Paraguaçu Extractive rubber reserve; 6: Federal highway BR 317 km 2; 7: Federal highway BR 317 km 10; 8: Federal highway BR 317 km 13; 9: Centro Neighborhood; 10: Cascata Neighborhood; 11: Bela Vista Neighborhood; 12: Santa QuitériaExtractive rubber reserve.

The identification of L. (V.) braziliensis as the predominant species is a relevant epidemiological factor, given that this species is the mainly responsible for the evolution of the mucosal form of ACL in Latin America11 , 27. In Assis Brasil/Brazil, from 2003 to 2010, there were 53.5% confirmed cases of the cutaneous form, 17% confirmed cases of the mucosal form, and 29.5% for which there was no information of the clinical form16. Besides its association with the mucosal form of the disease, L. (V.) braziliensis is also considered a therapeutic challenge14. The study found three recurring cases infected by that species, and from the six clinical cases that underwent two cycles of treatment with meglumine antimoniate (glucantime) for lesions heal, five were infected with L. (V.) braziliensis. L. (V.) shawi, the second most common species in this study, was recently identified in cutaneous lesions from patients of Madre de Dios/ Peru13, sporadically in cases of the Brazilian Amazonas region, namely in Pará, where it was isolated in cutaneous lesions12, and recently was also reported in Pernambuco5, Northeastern Brazil. The presence of this species could be linked to the presence of the phlebotomine Lu. whitmani 19. The identification of L. (V.) guyanensis and L. (L.) amazonensis has important epidemiological and clinical implications, because both species are associated with the development of metastases and a high failure rate of treatment with meglumine antimoniate9 , 11. L. (V.) guyanensis has been well characterized in the Amazon Basin, including Acre, Amapá, Roraima and Pará,with higher prevalence in the Amazonas State, where the parasite is associated with edentate animals and marsupials, and its main vector is Lu. umbratilis 9 , 19. The same vector has been reported in Acre/Brazil by AZEVEDO et al. 2. In Peru, L. (V.) guyanensis is one of the species more frequently found in cases of ACL, whereas L. (L.) amazonensis has a broad geographic distribution in Brazil, associated with different clinical forms, including the diffused form; its main reservoirs are rodents and marsupials, and the Lu. flaviscutellata and Lu. olmecaphlebotomines are the main vectors19. Although the finding of mixed infections by more than one species of Leishmania spp. obtained from clinical samples from a single lesion is rare, which was also observed in 14% of skin lesions characterized in Manaus/Brazil by COELHO et al. 6. For these authors, abundance and diversity of infected vectors in an endemic area may contribute to an increased reporting of cases with mixed infection. The average duration of the cutaneous disease was 55.9 ± 40.7 days (Q1 = 30.0, Q3 = 90 days, Md = 33 days and n = 72.9%). The evolution of the disease in the studied group had a healing rate of 97.3% (36/37), the percentage of patients that abandoned treatment was 2.7% (1/37) and 16.2% (6/37) of the patients (five infected with L. (V.) braziliensis and one with L. (V.) shawi) were administered two cycles of treatment with meglumine antimoniate. Antimonial chemotherapy studies in Latin America have shown different healing rates (26% - 100%), including healing failure. Several factors can influence the outcome of treatment, such as evolution, number, size and location of the lesions, as well as the Leishmania species causing the infection14 , 15. The early diagnosis in the majority of the population studied, the sensitivity of the diagnostic tests (100% for the mKDNA PCR and 86.4% for the hsp70 PCR) to confirm disease and the access to the correct ACL treatment may explain the overall treatment success. These conditions may also reduce the risk of developing a mucosal lesion, which could appear years after the primo-infection. Most of the ACL patients reported in this work have lived in a rural area (75.7%) for at least three years (70.3%), which suggests that these local cases are linked to activities in a forest environment (59.4%; 22/37). A higher percentage of male individuals was also observed (81.1%) and the age of the infected individuals varied from five to 46 years (Median = 23 years, Mean = 21.6 ± 10.6 years), with a higher percentage of young individuals in their productive years (15 - 40 years) (Table 1). Together, these data suggests that the transmission occurred outside of the residence during the working hours of the population studied. Such epidemiological profile has been observed, in Acre as in other regions of the Brazilian Amazon, which shows that ACL is an occupational disease, since most of the patients are men from rural areas engaged in activities associated with the permanence in the forest16 , 22 , 23 , 25. On the other hand, SILVA & MUNIZ22 reported a different epidemiological leishmaniasis profile in the microregion of Rio Branco, with increasing numbers in recent years of infected women and individuals living in urban areas, and with non-rural occupations. Although in that study the majority of positive cases are from rural areas, particularly Seringal Paraguaçu, Seringal Icuriã, Seringal São Francisco and Seringal Guanabara, which showed the highest indexes of ACL (13.5%, n = 5; 13.5%, n = 5; 11%, n = 4; 8%, n = 3, respectively), thus suggesting the classical rural/forest transmission, it should be noticed that several of those localities are in the periphery of the municipality urban center (Fig. 2). This is a matter of concern, because such proximity could favor the adaptation of infected vectors to intra and peridomicile in the municipality urban area.
Table 1

Epidemiological profile of patients examined in Assis Brasil (AC) with cutaneous lesions used in the diagnostic of Leishmania by PCR

Variables Positive % (CI 95%)
Sex Male 30 81.1 (66.1-91.3)
Female 7 18.9 (8.7-33.8)
Age 0 - 11 7 18.9 (8.7-33.8)
12 - 21 13 35.1 (21.1-51.4)
22 - 31 9 24.3 (12.5-39.9)
32 - 41 7 18.9 (8.7-33.8)
≥41 1 2.7 (0.1-12.6)
Profession Rural 22 59.4 (43.2-74.3)
Non-Rural 7 18.9 (8.7-33.8)
Others 8 22.6 (10.6-36.9)
Area Rural 28 75.7 (60.0-87.4)
Urban 9 24.3 (12.5-39.9)
Localities Seringal Paraguaçu 5 13.5
Seringal Icuriã 5 13.5
Seringal São Francisco 4 11
Seringal Guanabara 3 8
Federal highway BR 317 3 8
Urban area 9 24
Others 8 22
These data revealed a predominance of L. (V.) braziliensis in the ACL cases and that probably this disease is linked to rural life, particularly rural work. The presence of several Leishmania species supports a scenario of heterogeneous transmission, which calls for a broader epidemiological study that takes into consideration the vectors, reservoirs, virulence of the parasites and incidence of clinical forms.
  21 in total

1.  Use of FTA cards for direct sampling of patients' lesions in the ecological study of cutaneous leishmaniasis.

Authors:  Hirotomo Kato; Abraham G Cáceres; Tatsuyuki Mimori; Yuka Ishimaru; Amal S M Sayed; Megumi Fujita; Hiroyuki Iwata; Hiroshi Uezato; Lenin N Velez; Eduardo A L Gomez; Yoshihisa Hashiguchi
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

2.  Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment.

Authors:  Wilson Mayrink; Ana Cristina de Carvalho Botelho; Paulo Araújo Magalhães; Sebastião Mariano Batista; Antonio de Oliveira Lima; Odair Genaro; Carlos Alberto da Costa; Maria Norma de Melo; Marilene Susan Marques Michalick; Paul Williams; Magno Dias; Waleska Teixeira Caiaffa; Evaldo do Nascimento; George Luiz Lins Machado-Coelho
Journal:  Rev Soc Bras Med Trop       Date:  2006-02-23       Impact factor: 1.581

3.  [Epidemiology of American tegumentary leishmaniasis in the State of Acre, Brazilian Amazon].

Authors:  Natal Santos da Silva; Vitor Dantas Muniz
Journal:  Cad Saude Publica       Date:  2009-06       Impact factor: 1.632

4.  [American cutaneous leishmaniasis in the State of Acre, Brazil].

Authors:  N S Silva; A B Viana; J A Cordeiro; C E Cavasini
Journal:  Rev Saude Publica       Date:  1999-12       Impact factor: 2.106

5.  Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis.

Authors:  Jene Greyce S Oliveira; Fernanda O Novais; Camila I de Oliveira; Antonio C da Cruz Junior; Léon Fábio Campos; Any V da Rocha; Viviane Boaventura; Almério Noronha; Jackson M L Costa; Aldina Barral
Journal:  Acta Trop       Date:  2005-04       Impact factor: 3.112

Review 6.  Proven and putative vectors of American cutaneous leishmaniasis in Brazil: aspects of their biology and vectorial competence.

Authors:  Elizabeth Ferreira Rangel; Ralph Lainson
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-11       Impact factor: 2.743

Review 7.  Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review.

Authors:  Fernando T Silveira; Ralph Lainson; Carlos E P Corbett
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-07-19       Impact factor: 2.743

8.  Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil.

Authors:  Maria Edileuza F Brito; Maria S Andrade; Mitzi G Mendonça; Cláudio J Silva; Ericka L Almeida; Bruna S Lima; Simone M Félix; Frederico G C Abath; Grazielle C da Graça; Renato Porrozzi; Edna A Ishikawa; Jeffrey J Shaw; Elisa Cupolillo; Sinval P Brandão-Filho
Journal:  Trop Med Int Health       Date:  2009-08-25       Impact factor: 2.622

9.  Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

Authors:  Alejandro Llanos-Cuentas; Gianfranco Tulliano; Roger Araujo-Castillo; Cesar Miranda-Verastegui; Giovanna Santamaria-Castrellon; Luis Ramirez; Marcela Lazo; Simonne De Doncker; Marleen Boelaert; Jo Robays; Jean-Claude Dujardin; Jorge Arevalo; Francois Chappuis
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Pará state, Brazil, reveals a putative hybrid parasite, Leishmania (Viannia) guyanensis × Leishmania (Viannia) shawi shawi.

Authors:  Yara Lins Jennings; Adelson Alcimar Almeida de Souza; Edna Aoba Ishikawa; Jeffrey Shaw; Ralph Lainson; Fernando Silveira
Journal:  Parasite       Date:  2014-08-04       Impact factor: 3.000

View more
  10 in total

1.  Field Validation of SYBR Green- and TaqMan-Based Real-Time PCR Using Biopsy and Swab Samples To Diagnose American Tegumentary Leishmaniasis in an Area Where Leishmania (Viannia) braziliensis Is Endemic.

Authors:  Ciro Martins Gomes; Mariana Vicente Cesetti; Natália Aparecida de Paula; Sebastián Vernal; Gaurav Gupta; Raimunda Nonata Ribeiro Sampaio; Ana Maria Roselino
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

2.  Genotypic and phylogenic analyses of cutaneous leishmaniasis in Al Ahsa, Eastern Saudi Arabia during the coronavirus disease 2019 pandemic: First cases of Leishmania tropica with the predominance of Leishmania major.

Authors:  Abdullatif S Al-Rashed; Reem Al Jindan; Salma Al Jaroodi; Ahmed Al Mohanna; Ahmed Abdelhady; Ayman A El-Badry
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

3.  Drug-containing hydrophobic dressings as a topical experimental therapy for cutaneous leishmaniasis.

Authors:  Viviane Pereira; Neuza Biguinati de Barros; Sharon Rose Aragão Macedo; Amália Dos Santos Ferreira; Luiz Alberto Kanis; Roberto Nicolete
Journal:  J Parasit Dis       Date:  2019-09-20

4.  Phlebotomine sandfly (Diptera: Psychodidae) diversity and their Leishmania DNA in a hot spot of American Cutaneous Leishmaniasis human cases along the Brazilian border with Peru and Bolivia.

Authors:  Carolina Bioni Garcia Teles; Ana Paula de Azevedo Dos Santos; Rui Alves Freitas; Arley Faria José de Oliveira; Guilherme Maerschner Ogawa; Moreno Souza Rodrigues; Felipe Arley Costa Pessoa; Jansen Fernandes Medeiros; Luís Marcelo Aranha Camargo
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-06-10       Impact factor: 2.743

5.  Trichophoromyia auraensis is a putative vector

Authors:  Carolina Bioni Garcia Teles; Felipe Arley Costa Pessoa; Jansen Fernandes Medeiros; Luís Marcelo Aranha Camargo
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-07       Impact factor: 2.743

6.  Epidemiological aspects of American cutaneous leishmaniasis (ACL) in an endemic area of forest extractivist culture in western Brazilian Amazonia.

Authors:  Andreia Fernandes Brilhante; Leonardo Augusto Kohatsu Melchior; Vânia Lúcia Brandão Nunes; Cristiane de Oliveira Cardoso; Eunice Aparecida Bianchi Galati
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-13       Impact factor: 1.846

7.  Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon.

Authors:  Andreia Fernandes Brilhante; Luciana Lima; Ricardo Andrade Zampieri; Vânia Lúcia Brandão Nunes; Maria Elizabeth Cavalheiros Dorval; Patrícia Fernandes Nunes da Silva Malavazi; Leonardo Augusto Kohara Melchior; Edna Aoba Yassui Ishikawa; Cristiane de Oliveira Cardoso; Lucile Maria Floeter-Winter; Marta Maria Geraldes Teixeira; Eunice Aparecida Bianchi Galati
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

8.  Leishmania species in biopsies of patients with different clinical manifestations identified by high resolution melting and nested PCR in an Endemic district in Peru.

Authors:  Jesús Rojas-Jaimes; Nyshon Rojas-Palomino; James Pence; Andres G Lescano
Journal:  Parasite Epidemiol Control       Date:  2019-02-11

9.  Clinical and epidemiological profiles of patients with American cutaneous leishmaniasis from the states of Pernambuco and Amazonas, Brazil.

Authors:  Maria Gabriella Nunes de Melo; Rayana Carla Silva de Morais; Tayná Correia de Goes; Rômulo Pessoa E Silva; Rômulo Freire de Morais; Jorge Augusto de Oliveira Guerra; Maria Edileuza Felinto de Brito; Sinval Pinto Brandão Filho; Milena de Paiva Cavalcanti
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-25       Impact factor: 1.581

10.  Severe mucosal leishmaniasis with torpid and fatal evolution.

Authors:  Jesús Rojas Jaimes
Journal:  Clin Case Rep       Date:  2022-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.